Alexion Pharmaceuticals (ALXN) PT Raised to $170 at Raymond James
Raymond James raised its price target on Alexion Pharmaceuticals (NASDAQ: ALXN) to $170.00 while maintaining a Outperform rating.
Raymond James raised its price target on Alexion Pharmaceuticals (NASDAQ: ALXN) to $170.00 while maintaining a Outperform rating.